With activities controlling the pro‐tumorigenic properties of the IL‐6 cytokine family, STAT3 drives various oncogenic processes affecting cell cycle progression and survival, angiogenesis, tumour invasion and metastasis [4]. Here, STAT3 is linked to neoplasm.